Needham & Company LLC Reaffirms Hold Rating for Definitive Healthcare (NASDAQ:DH)

Needham & Company LLC restated their hold rating on shares of Definitive Healthcare (NASDAQ:DH) in a research report report published on Friday morning,Benzinga reports.

A number of other equities analysts have also commented on the stock. BTIG Research began coverage on shares of Definitive Healthcare in a report on Tuesday, September 17th. They issued a “buy” rating and a $7.00 price target on the stock. Robert W. Baird lowered their price target on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft cut their price objective on Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating for the company in a report on Friday, August 9th. Morgan Stanley decreased their price objective on Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating on the stock in a report on Tuesday, August 6th. Finally, Barclays reduced their price target on shares of Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat, Definitive Healthcare has an average rating of “Hold” and a consensus target price of $5.81.

Definitive Healthcare Stock Down 1.6 %

Shares of NASDAQ DH opened at $4.24 on Friday. The company has a current ratio of 2.40, a quick ratio of 2.40 and a debt-to-equity ratio of 0.27. The business has a 50-day moving average of $4.36 and a 200-day moving average of $4.98. The firm has a market capitalization of $500.02 million, a price-to-earnings ratio of -1.22, a PEG ratio of 6.27 and a beta of 1.33. Definitive Healthcare has a 12 month low of $3.19 and a 12 month high of $10.62.

Institutional Investors Weigh In On Definitive Healthcare

A number of large investors have recently added to or reduced their stakes in DH. Norden Group LLC bought a new stake in shares of Definitive Healthcare in the 1st quarter worth approximately $83,000. Oppenheimer Asset Management Inc. lifted its holdings in Definitive Healthcare by 40.5% in the first quarter. Oppenheimer Asset Management Inc. now owns 49,393 shares of the company’s stock worth $399,000 after buying an additional 14,229 shares during the period. Swiss National Bank boosted its position in Definitive Healthcare by 2.9% during the 1st quarter. Swiss National Bank now owns 103,300 shares of the company’s stock valued at $834,000 after acquiring an additional 2,900 shares in the last quarter. Susquehanna Fundamental Investments LLC purchased a new position in shares of Definitive Healthcare during the 1st quarter worth approximately $120,000. Finally, Vanguard Group Inc. raised its position in shares of Definitive Healthcare by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 4,535,377 shares of the company’s stock worth $36,600,000 after acquiring an additional 67,068 shares in the last quarter. Institutional investors own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.